Billiontoone (NASDAQ:BLLN) Downgraded to “Strong Sell” Rating by Zacks Research

Zacks Research cut shares of Billiontoone (NASDAQ:BLLN) from a hold rating to a strong sell rating in a research note issued to investors on Monday morning,Zacks reports.

A number of other analysts also recently weighed in on the stock. BTIG Research decreased their price target on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, August 6th. Guggenheim began coverage on shares of Billiontoone in a research note on Monday, June 29th. They set a “buy” rating and a $125.00 price objective on the stock. JPMorgan Chase & Co. dropped their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a research report on Thursday, August 6th. Wall Street Zen lowered shares of Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. Six equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Billiontoone currently has a consensus rating of “Hold” and an average target price of $126.71.

Billiontoone Trading Up 1.8%

Shares of BLLN opened at $92.32 on Monday. The firm has a market capitalization of $4.36 billion and a P/E ratio of 131.89. Billiontoone has a twelve month low of $61.96 and a twelve month high of $150.44. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17. The stock’s fifty day simple moving average is $114.66 and its 200 day simple moving average is $95.33.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, hitting analysts’ consensus estimates of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%.The company had revenue of $109.45 million for the quarter. On average, equities research analysts forecast that Billiontoone will post 0.83 earnings per share for the current year.

Insider Activity at Billiontoone

In related news, CTO David Tsao sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $102.27, for a total transaction of $2,045,400.00. Following the completion of the sale, the chief technology officer directly owned 1,000 shares in the company, valued at approximately $102,270. This trade represents a 95.24% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of Billiontoone stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $136.95, for a total value of $4,450,875.00. Following the completion of the transaction, the chief executive officer directly owned 20,000 shares in the company, valued at $2,739,000. This represents a 61.90% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 224,883 shares of company stock worth $25,698,744 over the last quarter. 50.22% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Billiontoone

Several institutional investors and hedge funds have recently modified their holdings of BLLN. Rossby Financial LCC bought a new stake in shares of Billiontoone in the 4th quarter valued at approximately $25,000. Wells Fargo & Company MN acquired a new stake in Billiontoone in the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC bought a new stake in Billiontoone during the fourth quarter worth approximately $80,000. Nano Cap New Millennium Growth Fund L P bought a new position in shares of Billiontoone in the fourth quarter valued at approximately $82,000. Finally, Thrive Wealth Management LLC acquired a new stake in shares of Billiontoone in the second quarter worth $240,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.